All Work

Chris Lange

Another Confusing Earnings Report From Yum

courtesy of KFCYum! Brands, Inc. (NYSE: YUM) reported its second-quarter financial results Tuesday after the market closed. The company had $0.69 in earnings per share (EPS) on $3.11 in revenue versus Thomson Reuters consensus…

Chris Lange · 11 years ago

BioCardia Sets Price For IPO

ThinkstockBioCardia, Inc. filed an amended S-1 form with the Securities and Exchange Commission (SEC) regarding its initial public offering. In this filing the company gave its expected price range as $12 to $14 for about…

Chris Lange · 11 years ago

Will BofA Discount to Book Value Enhance Earnings?

courtesy of Alex Proimos, via Wikimedia CommonsBank of America Corp. (NYSE: BAC) is scheduled to report its second quarter financial results Wednesday before the markets open. The consensus estimates from Thomson Reuters call for…

Chris Lange · 11 years ago

Match to Acquire PlentyOfFish

ThinkstockA subsidiary of IAC/InterActiveCorp (NASDAQ: IACI), The Match Group, announced Tuesday that it has entered into a definitive agreement to purchase PlentyOfFish. The total transaction is valued at $575 million. The transaction is expected…

Chris Lange · 11 years ago

Looking at the Upside in 4 Hotel Stocks

ThinkstockSo far 2015 has not been a good year for most hotel stocks, but this weakness could prove to be a good opportunity. In fact, one key analyst sees these hotel stocks on the…

Chris Lange · 11 years ago

Is Google Slowing Its Own Growth?

As Google continues to grow, it has to be mindful of how to more efficiently run its massive empire. According to the Wall Street Journal, Google is pursuing this strategy by curbing its hiring.

Chris Lange · 11 years ago

Why Biogen Is Now a Buy on Weakness

Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.

Chris Lange · 11 years ago

What to Expect From Yum Earnings

Yum! Brands is scheduled to release its second-quarter financial results Tuesday after the markets close.

Chris Lange · 11 years ago

Neos Therapeutics Sets Price for IPO

Neos Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) to price its initial public offering (IPO).

Chris Lange · 11 years ago